Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Incyte Corp

Incyte Corp (INCY)

Market is closed
News
Incyte Corporation (NASDAQ:INCY) Q4 2024 Earnings Call Transcript

Incyte Corporation (NASDAQ:INCY) Q4 2024 Earnings Call Transcript

Operator: Greetings, and welcome to the Incyte Fourth Quarter 2024 and Full Year Financial and Corporate Update Conference Call and Webcast. At this time all participants are in listen-only mode.

Keep Reading →

February 11th, 2025 - News Transcripts

Goldman Sachs' Top Growth Investors: 34 Stocks With The Highest Investment For Growth

Goldman Sachs' Top Growth Investors: 34 Stocks With The Highest Investment For Growth

With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle, and an economy with lower...

Keep Reading →

November 20th, 2024 - News

10 Best Immunotherapy Stocks to Buy Now

10 Best Immunotherapy Stocks to Buy Now

The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.

Keep Reading →

November 18th, 2024 - Hedge Funds News

Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects

Here’s How Jakafi’s Patent Expiry Impacts Incyte Corporation’s (INCY) Growth Prospects

Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer medication, Jakafi, expires in 2028.

Keep Reading →

November 16th, 2024 - News Stock Analysis

Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript

Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript

Operator: Greetings, and welcome to the Incyte Third Quarter Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.

Keep Reading →

October 31st, 2024 - News Transcripts

Incyte Corporation (NASDAQ:INCY) Q2 2024 Earnings Call Transcript

Incyte Corporation (NASDAQ:INCY) Q2 2024 Earnings Call Transcript

Operator: Hello, and welcome to the Incyte Second Quarter 2024 Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.

Keep Reading →

July 31st, 2024 - News Transcripts

Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript

Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript

Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS, expectations were $0.88.

Keep Reading →

May 1st, 2024 - News Transcripts

12 Best S&P 500 Stocks To Buy According to Analysts

12 Best S&P 500 Stocks To Buy According to Analysts

In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts.

Keep Reading →

March 31st, 2024 - News Quantitative Investing

30 Biggest Biotechnology Companies in the World

30 Biggest Biotechnology Companies in the World

In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.

Keep Reading →

March 17th, 2024 - Lists News

5 Biotech Stocks with Huge Potential

5 Biotech Stocks with Huge Potential

In this article, we will take a look at the 5 biotech stocks with huge potential.

Keep Reading →

March 8th, 2024 - Hedge Funds News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)